Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre

Osteoradionecrosis (ORN) of the jaws and medication-related osteonecrosis of the jaws (MRONJ) are uncommon but serious diseases affecting the oral and maxillofacial region with clinically similar appearance but distinct pathophysiology. Management of ORN and MRONJ is inherently challenging and the t...

Full description

Bibliographic Details
Main Authors:	Benjie Law, Hui Yuh Soh, Syed Nabil, Rama Krsna Rajandram, Abd Jabar Nazimi, Roszalina Ramli
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Applied Sciences
Subjects:	osteoradionecrosis ORN jaw bisphosphonate MRONJ osteonecrosis
Online Access:	https://www.mdpi.com/2076-3417/11/8/3365

Similar Items

Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
by: Falk Wehrhan, et al.
Published: (2019-03-01)

Reconstruction of mandibular defects in osteoradionecrosis and medication-related osteonecrosis of the jaw using fibula free flap and management of postoperative wound infections
by: Hyemin Oh, et al.
Published: (2022-12-01)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011-01-01)

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

History and Etiology of Jawbones Osteonecrosis
by: L. Hauer
Published: (2009-12-01)

Osteoradionecrosis of the jaw infected with Actinomyces sp: a challenge for clinical practice
by: Luciana Vieira Muniz, et al.
Published: (2014-11-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
by: Christian Gross, et al.
Published: (2017-06-01)

Osteoradionecrosis of the jaw: A mini review
by: Annu Singh, et al.
Published: (2022-07-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Is the Risk to Develop Osteoradionecrosis of the Jaws Following IMRT for Head and Neck Cancer Related to Co-Factors?
by: Eli Rosenfeld, et al.
Published: (2021-05-01)

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
by: Francesco Erovigni, et al.
Published: (2016-10-01)

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series
by: Filipa Frutuoso, et al.
Published: (2024-09-01)

Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study
by: Carlos Cesar De Antoni, et al.
Published: (2018-05-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report
by: Maryam Jalili Sadrabad, et al.
Published: (2023-07-01)

Osteoradionecrosis of jaw: An institutional experience
by: Saurabh Kumar, et al.
Published: (2018-01-01)

Implications in dental treatment during the use of antiresorptive drugs - a literature review
by: Aleksandra Dziewulska, et al.
Published: (2024-10-01)

Medication-Related Osteonecrosis of the Jaw—A Continuing Issue
by: Krzysztof Wróbel, et al.
Published: (2021-08-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis
by: Suad Aljohani
Published: (2023-09-01)

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
by: Mario Migliario, et al.
Published: (2017-03-01)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01)

The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study
by: Karapinar Gökay, et al.
Published: (2021-03-01)

A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials
by: Reem Hanna, et al.
Published: (2024-07-01)

MicroRNA in medication related osteonecrosis of the jaw: a review
by: Siti Salmiah Mohd Yunus, et al.
Published: (2023-04-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

MRONJ and VIT D insufficiency
by: Gholamreza Shirani, et al.
Published: (2021-07-01)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
by: Antonio Cortese, et al.
Published: (2021-04-01)

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
by: Gioacchino Catania, et al.
Published: (2016-12-01)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Cesar Augusto Migliorati
Published: (2022-04-01)

ADVANCED-PLATELET RICH FIBRIN – A NEW ACQUISITION IN JAW OSTEONECROSIS TREATMENT
by: Daniel Vlad, et al.
Published: (2018-01-01)

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
by: Christian Bacci, et al.
Published: (2021-01-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Medication-related osteonecrosis of jaw and rheumatoid arthritis: Revisiting the concepts
by: Adity Bansal, et al.
Published: (2021-01-01)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
by: Camilla Ottesen, et al.
Published: (2022-10-01)

Topical erythropoietin as a novel preventive and therapeutic agent in bisphosphonate-related osteonecrosis of the jaw
by: Pantea Nazeman, et al.
Published: (2016-01-01)